Daniel P. van Plew, EVP & General Mgr, Industrial at REGENERON PHARMACEUTICALS, INC. (REGN), sold 40,686 shares at $743.39 ($29.8M) on 2022-11-07, disclosed to the SEC on 2022-11-08.
Open-market sale of $29.8M REGN by EVP & General Mgr, Industrial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $725.84 | 26,114 | $19.0M | 63.6% |
| 2 | $742.79 | 100 | $74K | 0.2% |
| 3 | $743.39 | 1,100 | $818K | 2.7% |
| 4 | $744.61 | 2,032 | $1.5M | 5.1% |
| 5 | $744.61 | 2,032 | $1.5M | 5.1% |
| 6 | $745.51 | 1,468 |
| $1.1M |
| 3.7% |
| 7 | $745.51 | 1,468 | $1.1M | 3.7% |
| 8 | $746.56 | 2,782 | $2.1M | 7.0% |
| 9 | $746.56 | 2,782 | $2.1M | 7.0% |
| 10 | $747.20 | 404 | $302K | 1.0% |
| 11 | $747.20 | 404 | $302K | 1.0% |
| Total | $732.91 avg | 40,686 | $29.8M | 100% |
| Filing → |
| REGN | SELL | 2022-11-25 | $17.7M | — | Filing → |
| REGN | SELL | 2022-09-13 | $6.7M | — | Filing → |
| REGN | SELL | 2022-02-24 | $6.4M | — | Filing → |